ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+30.61%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$82.6M
AUM Growth
+$82.6M
(+8.2%)
Cap. Flow
+$2.74M
Cap. Flow
% of AUM
3.32%
Top 10 Holdings %
Top 10 Hldgs %
82.89%
Holding
26
New
8
Increased
1
Reduced
3
Closed
9
Top Buys
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$10.8M |
| 2 |
Geron
GERN
|
$6.82M |
| 3 |
Viridian Therapeutics
VRDN
|
$4.8M |
| 4 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$4.24M |
| 5 |
Black Diamond Therapeutics
BDTX
|
$4.04M |
Top Sells
| 1 |
BLU
BELLUS Health Inc.
BLU
|
$8.15M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$7.17M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$6.21M |
| 4 |
Mersana Therapeutics
MRSN
|
$4.9M |
| 5 |
Sarepta Therapeutics
SRPT
|
$2.87M |
Sector Composition
| 1 | Healthcare | 94.86% |